NETSCOUT > Case Studies > Assuring Performance & Availability of Biopharma Services with NETSCOUT

Assuring Performance & Availability of Biopharma Services with NETSCOUT

NETSCOUT Logo
Company Size
1,000+
Country
  • United States
Product
  • nGeniusONE Service Assurance platform
  • InfiniStreamNG appliances
  • vSTREAM virtual appliance
  • nGenius packet flow switch technology
Tech Stack
  • NETSCOUT Adaptive Service Intelligence (ASI) technology
  • 10G network environment
Implementation Scale
  • Enterprise-wide Deployment
Impact Metrics
  • Customer Satisfaction
  • Digital Expertise
  • Productivity Improvements
Technology Category
  • Analytics & Modeling - Real Time Analytics
  • Application Infrastructure & Middleware - API Integration & Management
  • Functional Applications - Enterprise Resource Planning Systems (ERP)
Applicable Industries
  • Healthcare & Hospitals
  • Pharmaceuticals
Applicable Functions
  • Business Operation
  • Product Research & Development
Use Cases
  • Predictive Maintenance
  • Real-Time Location System (RTLS)
Services
  • Software Design & Engineering Services
  • System Integration
About The Customer
The biopharma company is known for its innovative medicines that have earned brand-name recognition in the treatment of leukemia, cardiovascular diseases, diabetes, rheumatoid arthritis, and various forms of cancer. Their research & development (R&D) team is aligned to advance the company’s oncology, immunoscience, cardiovascular, and fibrotic disease portfolio, with subject matter experts working in several global innovation centers. With nearly $25 billion in annual revenue, the company’s growth is fueled by market advances in these therapeutic areas, as well as strategic acquisitions and technology partnerships. The company outsourced networked IT services to a leading managed services provider that offered the combined benefits of global reach and regional data center facilities.
The Challenge
The biopharma company was undergoing a digital transformation of its services and infrastructure, which required additional visibility. The company needed real-time monitoring of IT service platform transitions and new data center services. The company's technology landscape was frequently changing due to acquisitions, partnerships, and internal growth activities. There were near-term needs to monitor services in transition, including custom application performance and dependencies for apps running on servers being relocated across the enterprise, performance of DNS services migrating to a new hosting data center, and Office 365 performance in an upgraded 10G network environment. The IT provider also needed real-time monitoring of network traffic during data center migration activities, as well as network capacity management forecasting required to assess the need for a wide area network (WAN) upgrade.
The Solution
The IT provider selected the nGeniusONE platform for real-time monitoring across the biopharma business, providing an all-in-one real-time performance assurance solution that has been used to proactively monitor network, application, and Unified Communications & Collaboration (UC&C) services and assist in addressing cybersecurity challenges. NETSCOUT InfiniStreamNG appliances were deployed in acquired data center environments and remote offices to support 10, 40, and 100 GbE network speeds, provide nGeniusONE with the smart data necessary for generating the “single pane of glass” analytics views into network, application, UC, and business service performance at these facilities, and support ongoing network integration by generating smart data (incorporating NetFlow) required for nGeniusONE’s Link Utilization reporting and visualizations into identifying whether there were duplicate IPs involved in the in-progress network integration effort. The IT provider also deployed additional nGenius packet flow switch (PFS) appliances at these new service locations to streamline the monitoring architecture, optimize the flow of network packets to ISNG appliances, which then use NETSCOUT Adaptive Service Intelligence (ASI) technology to convert those packets into smart data for consumption by nGeniusONE performance analytics, and aggregate, replicate, distribute, and manage the flow of network packets to the Cybersecurity team to support security hardening.
Operational Impact
  • The biopharma's business-critical R&D, communications and collaboration platforms, and applications are always-on, with users benefitting from uninterrupted network service delivery.
  • Reliable R&D and business platform performance equips the biopharma to maintain industry leadership in releasing new, innovative solutions for disease management.
  • Strategic and tactical IT decisionmaking can be based on collaboration between the biopharma and the IT provider, with stakeholders from both organizations accessing nGeniusONE Service Dashboard, Monitor, and Report views for granular views of current-state network, application, UC&C, and other business service operations.
  • Technology partners can be assured their collaborations with the biopharma are conducted with integrity on reliable, secure technology platforms.
Quantitative Benefit
  • Avoided fines and regulatory issues with seamless, uninterrupted network services
  • Support increased pharma business and R&D efficiencies

Case Study missing?

Start adding your own!

Register with your work email and create a new case study profile for your business.

Add New Record

Related Case Studies.

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.